Marketing
Vivus
Vivus& Qnexa: Better for Diabetes, or Better for Weight Loss ...
Vivus Inc. (NASDAQ: VVUS) issued its awaited results on its mid-stage trial of its experimental drug Qnexa, showing that it lowered blood sugar levels and led to weight loss in patients with Type II diabetes. ...
Drugmaker Vivus Inc. said Wednesday its obesity drug candidate Qnexa met key weight loss goals in two late-stage studies.
Drugmaker Vivus Inc. said Wednesday its obesity drug candidate Qnexa met key weight loss goals in two late-stage studies.
Drugmaker Vivus Inc. said Wednesday its obesity drug candidate Qnexa met key weight loss goals in two late-stage studies.
Vivus Inc. (NASDAQ: VVUS) issued its awaited results on its mid-stage trial of its experimental drug Qnexa, showing that it lowered blood sugar levels and led to weight loss in patients with Type II diabetes. ...
apple news
how many tons of carbon make one carbon credit
nbc schedule
new ipod
watch obama s speech to kids
vietnam war timeline
michael rady
beatles
mary jo fernandez
fanged frog
Post je objavljen 09.09.2009. u 08:49 sati.